All terms in GO
| Label | Id | Description |
|---|---|---|
| gene expression involved in extracellular matrix organization | GO_1901148 |
Any gene expression that is involved in extracellular matrix organization. Gene expression includes both transcription to produce an RNA transcript, and the translation of that mRNA into protein. Protein maturation is included in gene expression when required to form an active form of a product from an inactive precursor form.
|
| salicylic acid binding | GO_1901149 |
Binding to salicylic acid.
|
| intermediate mesodermal cell fate commitment | GO_0048393 |
The process in which the developmental fate of a cell becomes restricted such that it will develop into an intermediate mesoderm cell.
|
| intermediate mesodermal cell fate determination | GO_0048394 |
The process in which a cell becomes capable of differentiating autonomously into a intermediate mesoderm cell regardless of its environment; upon determination, the cell fate cannot be reversed.
|
| intermediate mesoderm formation | GO_0048391 |
The process that gives rise to the intermediate mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
|
| intermediate mesodermal cell differentiation | GO_0048392 |
The process in which a relatively unspecialized cell acquires specialized features of an intermediate mesoderm cell.
|
| positive regulation of intermediate mesodermal cell fate determination | GO_0048397 |
Any process that activates or increases the frequency, rate or extent of intermediate mesoderm cell fate determination.
|
| regulation of intermediate mesodermal cell fate determination | GO_0048395 |
Any process that modulates the frequency, rate or extent of intermediate mesoderm cell fate determination.
|
| vistamycin metabolic process | GO_1901150 |
The chemical reactions and pathways involving vistamycin.
|
| intermediate mesodermal cell fate specification | GO_0048398 |
The process in which a cell becomes capable of differentiating autonomously into an intermediate mesoderm cell in an environment that is neutral with respect to the developmental pathway; upon specification, the cell fate can be reversed.
|
| vistamycin catabolic process | GO_1901151 |
The chemical reactions and pathways resulting in the breakdown of vistamycin.
|
| vistamycin biosynthetic process | GO_1901152 |
The chemical reactions and pathways resulting in the formation of vistamycin.
|
| negative regulation of intermediate mesodermal cell fate determination | GO_0048396 |
Any process that stops, prevents, or reduces the frequency, rate or extent of intermediate mesoderm cell fate determination.
|
| paromomycin metabolic process | GO_1901153 |
The chemical reactions and pathways involving paromomycin.
|
| paromomycin catabolic process | GO_1901154 |
The chemical reactions and pathways resulting in the breakdown of paromomycin.
|
| aminoglycoside antibiotic catabolic process | GO_0030649 |
The chemical reactions and pathways resulting in the breakdown of an aminoglycoside antibiotic, any member of a group of broad spectrum antibiotics, of similar toxicity and pharmacology, that contain an aminodeoxysugar, an amino- or guanidino-substituted inositol ring, and one or more residues of other sugars. The group includes streptomycin, neomycin, framycetin, kanamycin, paromomycin, and gentamicin.
|
| paromomycin biosynthetic process | GO_1901155 |
The chemical reactions and pathways resulting in the formation of paromomycin.
|
| neomycin metabolic process | GO_1901156 |
The chemical reactions and pathways involving neomycin.
|
| neomycin catabolic process | GO_1901157 |
The chemical reactions and pathways resulting in the breakdown of neomycin.
|
| neomycin biosynthetic process | GO_1901158 |
The chemical reactions and pathways resulting in the formation of neomycin.
|